Significant clinical response to a MEK inhibitor therapy in a patient with metastatic melanoma harboring an RAF1 fusion

Kevin B. Kim; Thomas Semrad; Alexa B. Schrock; Siraj M. Ali; Jeffrey S. Ross; Mark Singer; Mohammed Kashani-Sabet

doi:10.1200/PO.17.00138

Significant clinical response to a MEK inhibitor therapy in a patient with metastatic melanoma harboring an RAF1 fusion

Kevin B. Kim, Thomas Semrad, Alexa B. Schrock, Siraj M. Ali, Jeffrey S. Ross, Mark Singer, Mohammed Kashani-Sabet

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	JCO Precision Oncology
Volume	2
DOIs	https://doi.org/10.1200/PO.17.00138
State	Published - Jan 1 2018
Externally published	Yes

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1200/PO.17.00138

Cite this

@article{9cfc0ca3d3f84b88af70aff983f499f9,

title = "Significant clinical response to a MEK inhibitor therapy in a patient with metastatic melanoma harboring an RAF1 fusion",

author = "Kim, {Kevin B.} and Thomas Semrad and Schrock, {Alexa B.} and Ali, {Siraj M.} and Ross, {Jeffrey S.} and Mark Singer and Mohammed Kashani-Sabet",

year = "2018",

month = jan,

day = "1",

doi = "10.1200/PO.17.00138",

language = "English (US)",

volume = "2",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Significant clinical response to a MEK inhibitor therapy in a patient with metastatic melanoma harboring an RAF1 fusion

AU - Kim, Kevin B.

AU - Semrad, Thomas

AU - Schrock, Alexa B.

AU - Ali, Siraj M.

AU - Ross, Jeffrey S.

AU - Singer, Mark

AU - Kashani-Sabet, Mohammed

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85063286108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063286108&partnerID=8YFLogxK

U2 - 10.1200/PO.17.00138

DO - 10.1200/PO.17.00138

M3 - Article

VL - 2

JO - JCO Precision Oncology

JF - JCO Precision Oncology

SN - 2473-4284

ER -

Significant clinical response to a MEK inhibitor therapy in a patient with metastatic melanoma harboring an RAF1 fusion

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this